Bancreek Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,738
Closed -$4.53M 26
2022
Q3
$4.53M Buy
25,738
+2,186
+9% +$448K 3.9% 15
2022
Q2
$4.74M Buy
23,552
+2,458
+12% +$524K 3.71% 16
2022
Q1
$4.78M Buy
21,094
+7,636
+57% +$1.8M 3.12% 27
2021
Q4
$3.63M Buy
+13,458
New +$3.33M 3.4% 15

Other funds holding LH

Bancreek Capital Management's LH Position: Q4 2022 in Review

Bancreek Capital Management sold out of Labcorp (LH) in Q4 2022, closing a stake of 25,738 shares — an estimated $4.53M sold.

Bancreek Capital Management first reported a position in LH in Q4 2021 and held it in 4 quarters. The position peaked at $4.78M in Q1 2022. 970 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Bancreek Capital Management reported no remaining Labcorp position as of Q4 2022 after selling out during the quarter.
  • Bancreek Capital Management sold 25,738 Labcorp shares in Q4 2022, an estimated $4.53M.
  • Bancreek Capital Management first reported a position in Labcorp in Q4 2021 and held it in 4 quarters.
  • Bancreek Capital Management's Labcorp position peaked at $4.78M in Q1 2022.
  • 970 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Bancreek Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.